Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Schaff

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Contraception|December 17, 2009
Mifepristone: ten years laterEric A Schaff
Pediatric Clinics of North America|June 12, 2010
Preventing injuries and illnesses in the wildernessDavid Angert, Eric A Schaff
The Journal of Family Practice|October 22, 2013
Oral contraceptives: does formulation matter?Kathryn A Szabo, Eric A Schaff
Qualitative Health Research|April 27, 2004
Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortionStephen L Fielding, Eric A Schaff
Contraception|November 5, 2002
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancyEric A Schaff, Stephen L Fielding, Carolyn Westhoff
Contraception|January 11, 2005
Comparison of misoprostol plasma concentrations following buccal and sublingual administrationEric A Schaff, Robert DiCenzo, Stephen L Fielding
Perspectives on Sexual and Reproductive Health|May 7, 2002
Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiencesStephen L Fielding, Emme Edmunds, Eric A Schaff
Contraception|August 10, 2002
Clinicians' perception of sonogram indication for mifepristone abortion up to 63 daysStephen L Fielding, Eric A Schaff, Na-yon Nam
Contraception|June 23, 2004
Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot studyEmily M Godfrey, Jacinda T Mawson, Nancy L Stanwood, et al.
Obstetrics and Gynecology|May 4, 2004
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortionMitchell D Creinin, Michelle C Fox, Stephanie Teal, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Contraception|December 17, 2009
Mifepristone: ten years laterEric A Schaff
Pediatric Clinics of North America|June 12, 2010
Preventing injuries and illnesses in the wildernessDavid Angert, Eric A Schaff
The Journal of Family Practice|October 22, 2013
Oral contraceptives: does formulation matter?Kathryn A Szabo, Eric A Schaff
Qualitative Health Research|April 27, 2004
Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortionStephen L Fielding, Eric A Schaff
Contraception|November 5, 2002
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancyEric A Schaff, Stephen L Fielding, Carolyn Westhoff
Contraception|January 11, 2005
Comparison of misoprostol plasma concentrations following buccal and sublingual administrationEric A Schaff, Robert DiCenzo, Stephen L Fielding
Perspectives on Sexual and Reproductive Health|May 7, 2002
Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiencesStephen L Fielding, Emme Edmunds, Eric A Schaff
Contraception|August 10, 2002
Clinicians' perception of sonogram indication for mifepristone abortion up to 63 daysStephen L Fielding, Eric A Schaff, Na-yon Nam
Contraception|June 23, 2004
Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot studyEmily M Godfrey, Jacinda T Mawson, Nancy L Stanwood, et al.
Obstetrics and Gynecology|May 4, 2004
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortionMitchell D Creinin, Michelle C Fox, Stephanie Teal, et al.
Pageof 1